Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 4/20 | 0.41 |
| ▸ | CA1 | P00915 | 4/20 | 0.41 |
| ▸ | CA2 | P00918 | 4/20 | 0.41 |
| ▸ | CA4 | P22748 | 4/20 | 0.41 |
| ▸ | CA9 | Q16790 | 4/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | FAAH | O00519 | 2/20 | 0.35 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13685929 | 1.00 | CA12 (0.41) | CA12CA1CA2CA4CA9 | |
| SCHEMBL5052269 | 0.91 | — | — | |
| SCHEMBL8957403 | 0.83 | CA12 (0.50) | CA12CA1CA2CA4CA9 | |
| SCHEMBL25180667 | 0.83 | CA12 (0.50) | CA12CA1CA2CA4CA9 | |
| SCHEMBL1842696 | 0.83 | CA12 (0.50) | CA12CA1CA2CA4CA9 | |
| SCHEMBL25180691 | 0.83 | CA12 (0.50) | CA12CA1CA2CA4CA9 | |
| SCHEMBL25184217 | 0.83 | CA12 (0.50) | CA12CA1CA2CA4CA9 | |
| SCHEMBL324868 | 0.83 | CA12 (0.50) | CA12CA1CA2CA4CA9 | |
| SCHEMBL8957343 | 0.83 | CA12 (0.50) | CA12CA1CA2CA4CA9 | |
| SCHEMBL8709991 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3772511-B1 | PROCESS FOR THE PREPARATION OF A NITRIC OXIDE DONATING PROSTAGLANDIN ANALOGUE | NICOX SA (FR) | 2023-11-08 | — | — | EP | claimed |
| EP-3530649-B1 | PROCESS FOR THE PREPARATION OF A NITRIC OXIDE DONATING PROSTAGLANDIN ANALOGUE | NICOX SA (FR) | 2020-09-30 | — | — | EP | claimed |
| EP-4288413-A1 | PROCESS FOR THE PREPARATION OF A NITRIC OXIDE DONATING PROSTAGLANDIN ANALOGUE | Nicox S.A. (FR) | 2023-12-13 | — | — | EP | disclosed |
| WO-2022167070-A1 | PROCESS FOR THE PREPARATION OF A NITRIC OXIDE DONATING PROSTAGLANDIN ANALOGUE | NICOX S.A. (FR) | 2022-08-11 | — | — | WO | disclosed |
| WO-2021023693-A1 | PROCESS FOR THE PREPARATION OF A NITRIC OXIDE DONATING PROSTAGLANDIN ANALOGUE | NICOX S.A. (FR) | 2021-02-11 | — | — | WO | disclosed |
| EP-3530649-B1 | PROCESS FOR THE PREPARATION OF A NITRIC OXIDE DONATING PROSTAGLANDIN ANALOGUE | NICOX SA (FR) | 2020-09-30 | — | — | EP | disclosed |
| WO-2019162149-A1 | PROCESS FOR THE PREPARATION OF A NITRIC OXIDE DONATING PROSTAGLANDIN ANALOGUE | NICOX S.A. (FR) | 2019-08-29 | — | — | WO | disclosed |
| EP-3530649-A1 | PROCESS FOR THE PREPARATION OF A NITRIC OXIDE DONATING PROSTAGLANDIN ANALOGUE | Nicox S.A. (FR) | 2019-08-28 | — | — | EP | disclosed |